United Breweries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 28, 2025, 3:20 pm

Competitors of United Breweries Ltd

All Competitor Stocks of United Breweries Ltd

Quarterly Result

Last Updated: August 1, 2025, 9:45 am

Below is a detailed analysis of the quarterly data for United Breweries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 2,864.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,323.00 Cr. (Mar 2025) to 2,864.00 Cr., marking an increase of 541.00 Cr..
• For Expenses, as of Jun 2025, the value is 2,553.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,136.00 Cr. (Mar 2025) to 2,553.00 Cr., marking an increase of 417.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 311.00 Cr.. The value appears strong and on an upward trend. It has increased from 187.00 Cr. (Mar 2025) to 311.00 Cr., marking an increase of 124.00 Cr..
• For OPM %, as of Jun 2025, the value is 11.00%. The value appears strong and on an upward trend. It has increased from 8.00% (Mar 2025) to 11.00%, marking an increase of 3.00%.
• For Other Income, as of Jun 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 3.00 Cr..
• For Interest, as of Jun 2025, the value is 11.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 5.00 Cr..
• For Depreciation, as of Jun 2025, the value is 63.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 57.00 Cr. (Mar 2025) to 63.00 Cr., marking an increase of 6.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 248.00 Cr.. The value appears strong and on an upward trend. It has increased from 132.00 Cr. (Mar 2025) to 248.00 Cr., marking an increase of 116.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00%.
• For Net Profit, as of Jun 2025, the value is 184.00 Cr.. The value appears strong and on an upward trend. It has increased from 98.00 Cr. (Mar 2025) to 184.00 Cr., marking an increase of 86.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 6.95. The value appears strong and on an upward trend. It has increased from 3.69 (Mar 2025) to 6.95, marking an increase of 3.26.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:13 am

Growth

Last Updated: September 5, 2025, 1:50 pm

Balance Sheet

Last Updated: May 13, 2025, 2:30 pm

Below is a detailed analysis of the balance sheet data for United Breweries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 26.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 26.00 Cr..
• For Reserves, as of Mar 2025, the value is 4,337.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,152.00 Cr. (Mar 2024) to 4,337.00 Cr., marking an increase of 185.00 Cr..
• For Borrowings, as of Mar 2025, the value is 620.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 102.00 Cr. (Mar 2024) to 620.00 Cr., marking an increase of 518.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 3,239.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,773.00 Cr. (Mar 2024) to 3,239.00 Cr., marking an increase of 466.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 8,223.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7,053.00 Cr. (Mar 2024) to 8,223.00 Cr., marking an increase of 1,170.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,749.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,776.00 Cr. (Mar 2024) to 1,749.00 Cr., marking a decrease of 27.00 Cr..
• For CWIP, as of Mar 2025, the value is 253.00 Cr.. The value appears strong and on an upward trend. It has increased from 173.00 Cr. (Mar 2024) to 253.00 Cr., marking an increase of 80.00 Cr..
• For Investments, as of Mar 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 8.00 Cr..
• For Other Assets, as of Mar 2025, the value is 6,213.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,097.00 Cr. (Mar 2024) to 6,213.00 Cr., marking an increase of 1,116.00 Cr..
• For Total Assets, as of Mar 2025, the value is 8,223.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,053.00 Cr. (Mar 2024) to 8,223.00 Cr., marking an increase of 1,170.00 Cr..

Notably, the Reserves (4,337.00 Cr.) exceed the Borrowings (620.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for United Breweries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 16.71. This value is within the healthy range. It has increased from 15.51 (Mar 24) to 16.71, marking an increase of 1.20.
• For Diluted EPS (Rs.), as of Mar 25, the value is 16.71. This value is within the healthy range. It has increased from 15.51 (Mar 24) to 16.71, marking an increase of 1.20.
• For Cash EPS (Rs.), as of Mar 25, the value is 25.54. This value is within the healthy range. It has increased from 23.55 (Mar 24) to 25.54, marking an increase of 1.99.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 165.05. It has increased from 158.23 (Mar 24) to 165.05, marking an increase of 6.82.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 165.05. It has increased from 158.23 (Mar 24) to 165.05, marking an increase of 6.82.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 337.18. It has increased from 307.21 (Mar 24) to 337.18, marking an increase of 29.97.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 33.16. This value is within the healthy range. It has increased from 29.12 (Mar 24) to 33.16, marking an increase of 4.04.
• For PBIT / Share (Rs.), as of Mar 25, the value is 24.35. This value is within the healthy range. It has increased from 21.11 (Mar 24) to 24.35, marking an increase of 3.24.
• For PBT / Share (Rs.), as of Mar 25, the value is 22.89. This value is within the healthy range. It has increased from 20.84 (Mar 24) to 22.89, marking an increase of 2.05.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 16.73. This value is within the healthy range. It has increased from 15.54 (Mar 24) to 16.73, marking an increase of 1.19.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 16.71. This value is within the healthy range. It has increased from 15.51 (Mar 24) to 16.71, marking an increase of 1.20.
• For PBDIT Margin (%), as of Mar 25, the value is 9.83. This value is below the healthy minimum of 10. It has increased from 9.47 (Mar 24) to 9.83, marking an increase of 0.36.
• For PBIT Margin (%), as of Mar 25, the value is 7.22. This value is below the healthy minimum of 10. It has increased from 6.87 (Mar 24) to 7.22, marking an increase of 0.35.
• For PBT Margin (%), as of Mar 25, the value is 6.78. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 24) which recorded 6.78.
• For Net Profit Margin (%), as of Mar 25, the value is 4.96. This value is below the healthy minimum of 5. It has decreased from 5.05 (Mar 24) to 4.96, marking a decrease of 0.09.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.95. This value is below the healthy minimum of 8. It has decreased from 5.04 (Mar 24) to 4.95, marking a decrease of 0.09.
• For Return on Networth / Equity (%), as of Mar 25, the value is 10.12. This value is below the healthy minimum of 15. It has increased from 9.81 (Mar 24) to 10.12, marking an increase of 0.31.
• For Return on Capital Employeed (%), as of Mar 25, the value is 14.49. This value is within the healthy range. It has increased from 13.21 (Mar 24) to 14.49, marking an increase of 1.28.
• For Return On Assets (%), as of Mar 25, the value is 5.37. This value is within the healthy range. It has decreased from 5.81 (Mar 24) to 5.37, marking a decrease of 0.44.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.13. This value is within the healthy range. It has increased from 0.01 (Mar 24) to 0.13, marking an increase of 0.12.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.17. It has decreased from 1.22 (Mar 24) to 1.17, marking a decrease of 0.05.
• For Current Ratio (X), as of Mar 25, the value is 1.44. This value is below the healthy minimum of 1.5. It has decreased from 1.56 (Mar 24) to 1.44, marking a decrease of 0.12.
• For Quick Ratio (X), as of Mar 25, the value is 1.01. This value is within the healthy range. It has decreased from 1.08 (Mar 24) to 1.01, marking a decrease of 0.07.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.97. This value is within the healthy range. It has increased from 3.27 (Mar 24) to 5.97, marking an increase of 2.70.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 59.86. This value exceeds the healthy maximum of 50. It has increased from 48.36 (Mar 24) to 59.86, marking an increase of 11.50.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 39.19. This value is within the healthy range. It has increased from 31.88 (Mar 24) to 39.19, marking an increase of 7.31.
• For Earning Retention Ratio (%), as of Mar 25, the value is 40.14. This value is within the healthy range. It has decreased from 51.64 (Mar 24) to 40.14, marking a decrease of 11.50.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 60.81. This value is within the healthy range. It has decreased from 68.12 (Mar 24) to 60.81, marking a decrease of 7.31.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 68.17. This value is within the healthy range. It has decreased from 111.75 (Mar 24) to 68.17, marking a decrease of 43.58.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 37.41. This value is within the healthy range. It has decreased from 60.63 (Mar 24) to 37.41, marking a decrease of 23.22.
• For Enterprise Value (Cr.), as of Mar 25, the value is 53,037.52. It has increased from 45,671.76 (Mar 24) to 53,037.52, marking an increase of 7,365.76.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.95. This value exceeds the healthy maximum of 3. It has increased from 5.62 (Mar 24) to 5.95, marking an increase of 0.33.
• For EV / EBITDA (X), as of Mar 25, the value is 60.50. This value exceeds the healthy maximum of 15. It has increased from 59.32 (Mar 24) to 60.50, marking an increase of 1.18.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.93. This value exceeds the healthy maximum of 3. It has increased from 5.64 (Mar 24) to 5.93, marking an increase of 0.29.
• For Retention Ratios (%), as of Mar 25, the value is 40.13. This value is within the healthy range. It has decreased from 51.63 (Mar 24) to 40.13, marking a decrease of 11.50.
• For Price / BV (X), as of Mar 25, the value is 12.12. This value exceeds the healthy maximum of 3. It has increased from 10.96 (Mar 24) to 12.12, marking an increase of 1.16.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.93. This value exceeds the healthy maximum of 3. It has increased from 5.64 (Mar 24) to 5.93, marking an increase of 0.29.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness